Daniel John Townsend, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eyelid Neoplasms | 4 | 2013 | 89 | 1.060 |
Why?
|
| Eyelids | 5 | 2013 | 280 | 0.660 |
Why?
|
| Carcinoma, Basal Cell | 2 | 2011 | 564 | 0.480 |
Why?
|
| Nevus | 1 | 2013 | 206 | 0.380 |
Why?
|
| Palliative Care | 1 | 2021 | 3644 | 0.250 |
Why?
|
| Dibenzoxepins | 1 | 2003 | 28 | 0.220 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2003 | 125 | 0.200 |
Why?
|
| Anti-Allergic Agents | 1 | 2003 | 157 | 0.200 |
Why?
|
| Arachnida | 1 | 2015 | 4 | 0.130 |
Why?
|
| Horns | 1 | 2015 | 9 | 0.130 |
Why?
|
| Eyelid Diseases | 2 | 1993 | 157 | 0.110 |
Why?
|
| Orbital Diseases | 3 | 1995 | 178 | 0.080 |
Why?
|
| Prostheses and Implants | 2 | 1995 | 1279 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1706 | 0.080 |
Why?
|
| Gold | 1 | 1992 | 489 | 0.070 |
Why?
|
| Fetal Viability | 1 | 2007 | 23 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2013 | 630 | 0.070 |
Why?
|
| Facial Paralysis | 1 | 1992 | 346 | 0.070 |
Why?
|
| Microscopy, Polarization | 1 | 2007 | 88 | 0.070 |
Why?
|
| Meibomian Glands | 1 | 2006 | 74 | 0.070 |
Why?
|
| Enzymes | 1 | 2006 | 254 | 0.060 |
Why?
|
| Lacrimal Apparatus | 1 | 2006 | 223 | 0.060 |
Why?
|
| Conjunctiva | 1 | 2006 | 478 | 0.050 |
Why?
|
| Ophthalmic Solutions | 1 | 2003 | 315 | 0.050 |
Why?
|
| Osteomyelitis | 1 | 1986 | 408 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 1674 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 1977 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2640 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 3611 | 0.040 |
Why?
|
| Lasers | 1 | 2003 | 952 | 0.040 |
Why?
|
| Cornea | 1 | 2006 | 1332 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 13026 | 0.040 |
Why?
|
| Dermis | 1 | 1998 | 204 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2007 | 2894 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 11138 | 0.030 |
Why?
|
| Aged | 8 | 2013 | 171520 | 0.030 |
Why?
|
| Epidermis | 1 | 1998 | 539 | 0.030 |
Why?
|
| Orbit | 2 | 1995 | 459 | 0.030 |
Why?
|
| Humans | 14 | 2021 | 768451 | 0.030 |
Why?
|
| Phospholipids | 1 | 1998 | 783 | 0.030 |
Why?
|
| Blepharospasm | 1 | 1993 | 34 | 0.030 |
Why?
|
| Xanthomatosis | 1 | 1993 | 32 | 0.030 |
Why?
|
| Botulinum Toxins | 1 | 1993 | 189 | 0.020 |
Why?
|
| Adenoma, Sweat Gland | 1 | 1990 | 17 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2006 | 12813 | 0.020 |
Why?
|
| Apocrine Glands | 1 | 1990 | 32 | 0.020 |
Why?
|
| Facial Nerve | 1 | 1993 | 277 | 0.020 |
Why?
|
| Granuloma | 1 | 1993 | 331 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2003 | 4077 | 0.020 |
Why?
|
| Sweat Gland Neoplasms | 1 | 1990 | 116 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2003 | 12450 | 0.020 |
Why?
|
| Female | 8 | 2011 | 396943 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 59680 | 0.020 |
Why?
|
| Male | 9 | 2015 | 364781 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2015 | 1882 | 0.020 |
Why?
|
| Progesterone Reductase | 1 | 2006 | 14 | 0.020 |
Why?
|
| Steryl-Sulfatase | 1 | 2006 | 11 | 0.020 |
Why?
|
| Steroid Isomerases | 1 | 2006 | 19 | 0.020 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2006 | 58 | 0.020 |
Why?
|
| Aromatase | 1 | 2006 | 147 | 0.020 |
Why?
|
| Glucuronosyltransferase | 1 | 2006 | 136 | 0.020 |
Why?
|
| Staphylococcus epidermidis | 1 | 1986 | 123 | 0.020 |
Why?
|
| Systems Integration | 1 | 2007 | 429 | 0.020 |
Why?
|
| Eye Foreign Bodies | 1 | 1986 | 51 | 0.020 |
Why?
|
| Surgery, Plastic | 1 | 1992 | 650 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2007 | 848 | 0.010 |
Why?
|
| Blepharoptosis | 1 | 1986 | 145 | 0.010 |
Why?
|
| History, 20th Century | 1 | 1992 | 2772 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 666 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2006 | 708 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 3530 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2003 | 54914 | 0.010 |
Why?
|
| Phosphorus Isotopes | 1 | 1998 | 125 | 0.010 |
Why?
|
| Middle Aged | 5 | 2003 | 223418 | 0.010 |
Why?
|
| Adult | 4 | 2003 | 223542 | 0.010 |
Why?
|
| Animals | 3 | 2015 | 169418 | 0.010 |
Why?
|
| Orbit Evisceration | 1 | 1995 | 9 | 0.010 |
Why?
|
| Eye Enucleation | 1 | 1995 | 128 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 3408 | 0.010 |
Why?
|
| Porosity | 1 | 1995 | 352 | 0.010 |
Why?
|
| Durapatite | 1 | 1995 | 166 | 0.010 |
Why?
|
| Asthma | 1 | 1993 | 6274 | 0.010 |
Why?
|
| Surgical Wound Dehiscence | 1 | 1995 | 216 | 0.010 |
Why?
|
| Polyethylenes | 1 | 1995 | 290 | 0.010 |
Why?
|
| Prognosis | 1 | 1992 | 30028 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1986 | 9382 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1992 | 39430 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1998 | 3783 | 0.000 |
Why?
|
| Nerve Regeneration | 1 | 1993 | 801 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1993 | 20762 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1986 | 7471 | 0.000 |
Why?
|
| Neovascularization, Pathologic | 1 | 1995 | 2643 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1993 | 2714 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1993 | 10784 | 0.000 |
Why?
|
| Mice | 1 | 2007 | 82045 | 0.000 |
Why?
|
| Child | 1 | 1986 | 80863 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1995 | 42623 | 0.000 |
Why?
|
| Adolescent | 1 | 1995 | 89168 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1995 | 81834 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1993 | 36840 | 0.000 |
Why?
|